TrialDiabetes, obesity & metabolism2020

A greater proportion of participants with type 2 diabetes achieve treatment targets with insulin degludec/liraglutide versus insulin glargine 100 units/mL at 26 weeks: DUAL VIII, a randomized trial designed to resemble clinical practice.

Giorgio Sesti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.